Output details
3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
Keele University
Return to search
Output 0 of 0 in the submission
Article title
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial.
Type
D - Journal article
Title of journal
Lancet
Article number
-
Volume number
382
Issue number
9897
First page of article
1021
ISSN of journal
1474-547X
Year of publication
2013
Number of additional authors
25
Additional information
The author made a substantial contribution to carrying out the study (including acquisition of study data). The author helped draft the output and critique the output for important intellectual content.
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
1
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-